Reshaping Immunosuppressive Tumor Microenvironment Using Ferroptosis/Cuproptosis Nanosensitizers for Enhanced Radioimmunotherapy
Authors:
- 15 October 2024
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (51)
Abstract
Radiotherapy, a traditional cancer treatment, not only controls local tumor growth but also potentially induces immunogenic cell death, initiating systemic immune responses. However, radiotherapy resistance and immunosuppressive tumor microenvironments often limit the potency of radiation‐induced anti‐tumor immune responses, rendering them insufficient for clinical applications. Consequently, trimetallic nanoparticles are constructed with dual enzymatic activity, AuBiCu‐distearoyl phosphoethanolamine‐PEG nanoparticles (AuBiCu‐PEG NPs), to synergistically improve radiotherapy resistance through X‐ray deposition, hypoxia alleviation, and ferroptosis and cuproptosis induction. This approach promotes radiotherapy‐induced immunogenic cell death and boosts anti‐tumor immune responses. Furthermore, AuBiCu‐PEG NPs effectively reversed radiation‐induced upregulation of programmed cell death 1 ligand 1 (PD‐L1), inhibit tumor immune evasion, and reshaped the immune microenvironment. Non‐invasive and real‐time longitudinal monitoring of nanoparticle accumulation in tumors can be achieved using spectral computed tomography (CT) and photoacoustic (PA) imaging. In summary, the designed AuBiCu‐PEG NPs serve as promising nanoplatforms for immune microenvironment remodeling and can be used in multimodal molecular imaging‐guided ferroptosis‐cuproptosis‐enhanced radiotherapy.Keywords
Funding Information
- National Outstanding Youth Foundation of China (82302140)
- Basic and Applied Basic Research Foundation of Guangdong Province (2017A050506011, 2018030310343, 2020B1515020008, 2021A1515012542, 2021A1515011882)
- National Natural Science Foundation of China (81871334, 81801764, 82072056, 51937010)
This publication has 33 references indexed in Scilit:
- A Vacancy‐Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co‐Activated ImmunotherapyAdvanced Materials, 2024
- Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor ImmunotherapyAdvanced Science, 2024
- Peptide‐Driven Proton Sponge Nano‐Assembly for Imaging and Triggering Lysosome‐Regulated Immunogenic Cancer Cell DeathAdvanced Materials, 2024
- Alendronate PtIV Prodrug Amphiphile for Enhanced Chemotherapy Targeting and Bone Destruction Inhibition in OsteosarcomaAdvanced Healthcare Materials, 2023
- Bimetallic Ions Functionalized Metal–Organic‐Framework Nanozyme for Tumor Microenvironment Regulating and Enhanced Photodynamic Therapy for Hypoxic TumorAdvanced Healthcare Materials, 2023
- Immunogenic Cell Death Inducing Metal Complexes for Cancer TherapyAngewandte Chemie International Edition, 2023
- Diagnosis and Treatment of Metastatic Colorectal CancerJAMA, 2021
- Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer ImmunotherapyAdvanced Materials, 2019
- Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer ImmunotherapyAngewandte Chemie International Edition, 2018
- Nano‐Gold as Artificial Enzymes: Hidden TalentsAdvanced Materials, 2014